Keywords: shire, secures, successor, adderall, xr, fda, approves

Shire secures successor to Adderall XR as US FDA approves Vyvanse: another predicted blockbuster

Article | 05 March 2007

UK drugmaker Shire says that the US Food and Drug Administration has granted marketing approval for Vyvanse (lisdexamfetamine dimesylate; formerly ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Shire

Go to company listing

Related Drugs

lisdexamfetamine dimesylate

Vyvanse

Amphetamine, Dextroamphetamine Mixed Salts

Adderall

Adderall XR

Go to drug listing